Literature DB >> 27365026

[Treat to target and personalized medicine (precision medicine)].

J Detert1, G R Burmester2.   

Abstract

Mesh：

Year:  2016        PMID： 27365026     DOI： 10.1007/s00393-016-0137-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  102 in total

1.  Very high levels of anti-citrullinated protein antibodies are associated with HLA-DRB1*15 non-shared epitope allele in patients with rheumatoid arthritis.

Authors:  Judit Laki; Emeli Lundström; Omri Snir; Johan Rönnelid; Izabella Ganji; Anca I Catrina; Camilla Bengtsson; Saedis Saevarsdottir; Marius C Wick; Lars Alfredsson; Lars Klareskog; Leonid Padyukov
Journal:  Arthritis Rheum       Date:  2012-07

2.  Pharmacogenomics: the importance of accurate phenotypes.

Authors:  David Gurwitz; Munir Pirmohamed
Journal:  Pharmacogenomics       Date:  2010-04       Impact factor: 2.533

3.  Work disability in rheumatoid arthritis 10 years after the diagnosis.

Authors:  T Sokka; H Kautiainen; T Möttönen; P Hannonen
Journal:  J Rheumatol       Date:  1999-08       Impact factor: 4.666

Review 4.  From the era of genome analysis to the era of genomic drug discovery: a pioneering example of rheumatoid arthritis.

Authors:  Y Okada
Journal:  Clin Genet       Date:  2014-09-08       Impact factor: 4.438

5.  Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.

Authors:  B Combe; I Logeart; M C Belkacemi; S Dadoun; T Schaeverbeke; J P Daurès; M Dougados
Journal:  Ann Rheum Dis       Date:  2014-01-07       Impact factor: 19.103

6.  Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry.

Authors:  M L Hetland; H M Lindegaard; A Hansen; J Pødenphant; J Unkerskov; V S Ringsdal; M Østergaard; U Tarp
Journal:  Ann Rheum Dis       Date:  2008-02-13       Impact factor: 19.103

7.  The Comparison of Matching Methods Using Different Measures of Balance: Benefits and Risks Exemplified within a Study to Evaluate the Effects of German Disease Management Programs on Long-Term Outcomes of Patients with Type 2 Diabetes.

Authors:  Birgit Fullerton; Boris Pöhlmann; Robert Krohn; John L Adams; Ferdinand M Gerlach; Antje Erler
Journal:  Health Serv Res       Date:  2016-02-03       Impact factor: 3.402

8.  High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.

Authors:  Steve Eyre; John Bowes; Dorothée Diogo; Annette Lee; Anne Barton; Paul Martin; Alexandra Zhernakova; Eli Stahl; Sebastien Viatte; Kate McAllister; Christopher I Amos; Leonid Padyukov; Rene E M Toes; Tom W J Huizinga; Cisca Wijmenga; Gosia Trynka; Lude Franke; Harm-Jan Westra; Lars Alfredsson; Xinli Hu; Cynthia Sandor; Paul I W de Bakker; Sonia Davila; Chiea Chuen Khor; Khai Koon Heng; Robert Andrews; Sarah Edkins; Sarah E Hunt; Cordelia Langford; Deborah Symmons; Pat Concannon; Suna Onengut-Gumuscu; Stephen S Rich; Panos Deloukas; Miguel A Gonzalez-Gay; Luis Rodriguez-Rodriguez; Lisbeth Ärlsetig; Javier Martin; Solbritt Rantapää-Dahlqvist; Robert M Plenge; Soumya Raychaudhuri; Lars Klareskog; Peter K Gregersen; Jane Worthington
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

9.  Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.

Authors:  S A Owen; S L Hider; P Martin; I N Bruce; A Barton; W Thomson
Journal:  Pharmacogenomics J       Date:  2012-03-27       Impact factor: 3.550

10.  A genetic variant in osteoprotegerin is associated with progression of joint destruction in rheumatoid arthritis.

Authors:  Rachel Knevel; Diederik P C de Rooy; Tore Saxne; Elisabet Lindqvist; Martha K Leijsma; Nina A Daha; Bobby P C Koeleman; Roula Tsonaka; Jeanine J Houwing-Duistermaat; Joris J M Schonkeren; Rene E M Toes; Tom W J Huizinga; Elisabeth Brouwer; Anthony G Wilson; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2014-05-07       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.